EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 15 November 2021. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q1 Un-audited): Consolidated EPS was Tk. 5.64 for July-September 2021 as against Tk. 4.44 for July-September 2020; Consolidated NOCFPS was Tk. 6.61 for July-September 2021 as against Tk. 3.30 for July-September 2020. Consolidated NAV per share was Tk. 108.71 as on September 30, 2021 and Tk. 102.54 as on June 30, 2021. (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6191d0ac03147376eaa75b0f
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.